Integrated Diagnostics Holdings plc
IDGXF
$0.64
$0.046.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 128.68M | 148.93M | 129.68M | 134.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 128.68M | 148.93M | 129.68M | 134.76M |
| Cost of Revenue | -- | 77.87M | 91.65M | 80.97M | 83.83M |
| Gross Profit | -- | 50.81M | 57.28M | 48.72M | 50.93M |
| SG&A Expenses | -- | 22.61M | 36.26M | 22.13M | 24.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -1.28M | -12.28M | -312.20K | -202.10K |
| Total Operating Expenses | -- | 99.19M | 115.63M | 102.78M | 108.00M |
| Operating Income | -- | 29.48M | 33.30M | 26.90M | 26.76M |
| Income Before Tax | -- | 28.26M | 44.79M | 28.49M | 32.35M |
| Income Tax Expenses | -- | 10.18M | 13.88M | 7.51M | 10.69M |
| Earnings from Continuing Operations | -- | 18.08 | 30.91 | 20.98 | 21.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 906.60K | 2.58M | 2.10M | 2.14M |
| Net Income | -- | 18.99M | 33.49M | 23.07M | 23.80M |
| EBIT | -- | 29.48M | 33.30M | 26.90M | 26.76M |
| EBITDA | -- | 35.91M | 40.21M | 34.49M | 34.79M |
| EPS Basic | -- | 0.03 | 0.06 | 0.04 | 0.04 |
| Normalized Basic EPS | -- | 0.03 | 0.05 | 0.03 | 0.04 |
| EPS Diluted | -- | 0.03 | 0.06 | 0.04 | 0.04 |
| Normalized Diluted EPS | -- | 0.03 | 0.05 | 0.03 | 0.04 |
| Average Basic Shares Outstanding | -- | 2.36B | 2.36B | 2.38B | 2.40B |
| Average Diluted Shares Outstanding | -- | 2.36B | 2.36B | 2.38B | 2.40B |
| Dividend Per Share | -- | -- | 0.02 | -- | -- |
| Payout Ratio | -- | 0.13% | -- | -- | -- |